Trial Profile
A Post-Marketing Surveillance Study on the Safety and Effectiveness of Doripenem Among Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2013
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections; Intra-abdominal infections; Nosocomial pneumonia; Urinary tract infections; Ventilator associated pneumonia
- Focus Adverse reactions
- Sponsors Janssen Pharmaceutica
- 24 Jan 2013 New trial record